Loading
Life sciences · Journal article
Journal of Medicinal Chemistry · October 3, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Abstract Ferroptosis, an immunogenic iron-dependent cell death driven by lipid peroxidation, holds promise for treating triple-negative breast cancer (TNBC). However, its efficacy is severely compromised by restricted iron availability and the potent GPX4/GSH defense system. Herein, we developed a mitochondria-targeted prodrug by conjugating sulfasalazine (SAS) to triphenylphosphonium (TPP) via a disulfide-containing linker, which self-assembles into carrier-free nanoassemblies (ASSP). After cellular internalization and lysosomal release, SAS-SS-TPP accumulates in mitochondria, where thiol-disulfide exchange depletes GSH, orchestrates GPX4 antiferroptosis system failure, and liberates SAS. The released SAS elicits PINK1-dependent mitophagy, unleashing mitochondrial iron stores, amplifying the labile iron pool, and driving Fenton-reaction-mediated lipid peroxidation. By synergizing “mitophagy-fueled iron surge” and “GPX4/GSH defense disruption”, ASSP evokes potent ferroptosis and antitumor immunity, dramatically suppressing TNBC tumor growth and metastasis. This work presents a nanotherapeutic strategy that leverages mitophagy to potentiate ferroptosis and immunotherapy, offering a promising approach for cancer therapy.